Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer | MicrobiomeTrials← Back to trialsNCT07226544
Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-06-08Est. Completion: 2027-09-08
Enrollment target: 31 participants Locations- City of Hope Medical Center, Duarte, California, United States
Other microbiome trials you might be interested in
Malignant Solid TumorsOther Neoplasms Solid TumorsPediatric Solid TumorRefractory Solid TumorsSolid Tumor
Background:
Approximately 150 cases of cancer per one million per year are considered rare cancers. While all tumors or…
Bethesda, United StatesEst. completion May 31, 2028
AdenocarcinomaProstate NeoplasmsProstate CancerRenal Cell CarcinomaVon Hippel Lindau Disease
This study will evaluate the accuracy and effectiveness of an experimental tracking device for locating abnormalities du…
Bethesda, United StatesCompleted Jun 2, 2026